Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | CASP1 | P29466 | 1/20 | 0.52 |
| ▸ | CASP7 | P55210 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.52 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | F2 | P00734 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31296110 | 1.00 | MEN1 (0.52) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL10733095 | 0.97 | ESR2 (0.50) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL10733080 | 0.97 | ESR2 (0.50) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL11067469 | 0.89 | ALDH1A1 (0.65) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| Sulfuric Acid SCHEMBL10726991 | 0.89 | ESR2 (0.44) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| Hydrochloric Acid SCHEMBL28313625 | 0.87 | ALDH1A1 (0.62) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL11058889 | 0.82 | BACE1 (0.52) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL11058519 | 0.82 | KDM4E (0.51) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL14077239 | 0.80 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1CASP1CASP7 | |
| SCHEMBL2368334 | 0.80 | ALDH1A1 (0.54) | MEN1KMT2AALDH1A1CASP1CASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3759171-B9 | AN OPHTHALMIC DEVICE COMPRISING POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT | JOHNSON & JOHNSON VISION CARE (US) | 2023-05-24 | — | — | EP | claimed |
| EP-3759171-B1 | AN OPHTHALMIC DEVICE COMPRISING POLYMERIZABLE ABSORBERS OF UV AND HIGH ENERGY VISIBLE LIGHT | JOHNSON & JOHNSON VISION CARE (US) | 2023-02-22 | — | — | EP | claimed |
| EP-0031407-B1 | SUBSTITUTED 3,6 BIS-(AMINOALKOXY)ACRIDINES, AND A PROCESS FOR THEIR PREPARATION | AMERICAN CYANAMID COMPANY (US) | 1987-04-22 | — | — | EP | claimed |
| CN-106471067-B | Azetidine substituted fluorescent compounds | 霍华德休斯医学研究所 | 2020-12-08 | — | — | CN | disclosed |
| EP-3126451-B1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | HUGHES HOWARD MED INST (US) | 2020-09-09 | — | — | EP | disclosed |
| US-20190107534-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | HOWARD HUGHES MEDICAL INSTITUTE | 2019-04-11 | — | — | US | disclosed |
| US-10161932-B2 | Azetidine-substituted fluorescent compounds | HOWARD HUGHES MEDICAL INSTITUTE (US) | 2018-12-25 | — | — | US | disclosed |
| US-20180284105-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | HOWARD HUGHES MEDICAL INSTITUTE | 2018-10-04 | — | — | US | disclosed |
| US-10018624-B1 | Azetidine-substituted fluorescent compounds | HOWARD HUGHES MEDICAL INSTITUTE (US) | 2018-07-10 | — | — | US | disclosed |
| US-20180172677-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | HOWARD HUGHES MEDICAL INSTITUTE | 2018-06-21 | — | — | US | disclosed |
| US-9933417-B2 | Azetidine-substituted fluorescent compounds | HOWARD HUGHES MEDICAL INSTITUTE (US) | 2018-04-03 | — | — | US | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| US-4696936-A | 3,6-bis (substituted) acridine N-oxides and N,N-dioxides and methods of restoring, stimulating or enhancing the immune system with them | AMERICAN CYANAMID COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
| US-4696935-A | 3,6-BIS(2-(PIPERIDINO)ETHOXY)ACRIDINE | AMERICAN CYANAMID COMPANY (US) | 1987-09-29 | — | — | US | disclosed |
| EP-0031407-B1 | SUBSTITUTED 3,6 BIS-(AMINOALKOXY)ACRIDINES, AND A PROCESS FOR THEIR PREPARATION | AMERICAN CYANAMID COMPANY (US) | 1987-04-22 | — | — | EP | disclosed |
| EP-0180812-A2 | 3,6 Bis(substituted) acridine derivatives | AMERICAN CYANAMID COMPANY (US) | 1986-05-14 | — | — | EP | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4314061-A | Certain 3,6-bis-(heteroaminoalkoxy) acridines | AMERICAN CYANAMID COMPANY | 1982-02-02 | — | — | US | disclosed |
| EP-0031407-A1 | Substituted 3,6 bis-(aminoalkoxy)acridines, and a process for their preparation | AMERICAN CYANAMID COMPANY (US) | 1981-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180284105-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | AANAT, HNMT, CHAT | MEN1 2400/4885KMT2A 3092/4885ALDH1A1 298/4885 |
| US-10018624-B1 | Azetidine-substituted fluorescent compounds | AANAT, HNMT, CHAT | MEN1 2400/4885KMT2A 3092/4885ALDH1A1 298/4885 |
| US-20180172677-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | AANAT, HNMT, CHAT | MEN1 2400/4885KMT2A 3092/4885ALDH1A1 298/4885 |
| US-20190107534-A1 | AZETIDINE-SUBSTITUTED FLUORESCENT COMPOUNDS | AANAT, HNMT, CHAT | MEN1 2400/4885KMT2A 3092/4885ALDH1A1 298/4885 |
| US-10161932-B2 | Azetidine-substituted fluorescent compounds | AANAT, HNMT, CHAT | MEN1 2400/4885KMT2A 3092/4885ALDH1A1 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.